I don’t know what to do any more. As you all know, I sent out a passionate email to almost EVERYONE in my contacts list in early 2021, begging them not to take the jabs. Then I left them alone, no follow up begs, no harassment. I received two replies - one asking me if my email had been hacked and one asking if the lockdowns had sent me off my rocker.
This week, I’ve received two emails from people copied on that email asking for help with what they believe is their vaccine-induced cancer and debilitating tinnitus. I’ve sent what we’ve discussed here about potential cancer treatments using fenbendazole, mebendazole and IVM. For the man with the bad case of tinnitus, I don’t know where to point him, aside from trying a high dose of prednisone for an extended time. The medical community is responding slowly (cancer patient in Canada) or not at all (tinnitus patient).
I feel very helpless and so very sorry that people I care about are suffering. Both have confessed to thinking I was a conspiracy theorist 4 years ago and both have linked their conditions to the jabs. People are waking up, but for some it’s too late. If anyone knows anything that can help my tinnitus friend, I’d love to hear it and pass it along.
| Treatment/Method | Description/Source | Reported Success | Score |
|---|---|---|---|
| Transcranial Magnetic Stimulation (rTMS) | Scientific case: Pfizer vaccine-associated tinnitus relieved with rTMS. From PubMed and PMC articles. Recent reports confirm relief. | Complete relief; THI score from 96 to 6 in one case. | 10 |
| Steroids (e.g., Prednisone, Dexamethasone) | Medical reports and anecdotes: Used for post-vaccine tinnitus. X posts mention resolution after steroids. ENT steroid shot resolved inflammation. | Significant reduction or complete resolution in acute cases; one case resolved tinnitus after vertigo. | 9 |
| Lenire® Tinnitus Treatment | Patient story: Strong response after COVID-related tinnitus. From company site and anecdotes. | Returned to normal life; improved sleep and symptoms. | 8 |
| Lidocaine (Transdermal Patch) | Study: 5% patch reduced symptoms by half in 2 months. X mentions for auditory nerve blocking. | Halved symptoms; improved hearing and sleep. | 8 |
| DMSO-Based Spray | Study: 15 patients improved in 1 month. Clinic in NYC reported immediate relief and cures. | Significant improvement; vertigo and insomnia resolved; many permanently cured. | 8 |
| Imatinib | X post: Worked for Long COVID, including tinnitus. Symptom-free aside from tinnitus but overall improvement. | Significant improvement; lost fluid retention weight. | 7 |
| Sulodexide | Anecdotal from X: Improved pulsatile tinnitus in Long COVID; helped headaches. | Greatly improved quality of life. | 7 |
| Nicotine (Lozenge/Patch) | Multiple X anecdotes: 2mg lozenge (21-day protocol) or patch improved tinnitus and palps. Resolved ear clogging post-COVID. | Significant improvement or resolution; back to 90% in some. | 6 |
| Novavax Booster | X story: Resolved tinnitus and brain fog from COVID after booster. | Completely resolved. | 6 |
| Supplements (NAC, Taurine, IP-6, Quercetin, OLE) + IV Therapy | X physician: 80-90% improvement in severe post-vax tinnitus. | 80-90% improvement; better rest. | 6 |
| Magnesium Supplements | X anecdote: Improved tinnitus dramatically after starting for post-vax ringing. | Dramatically improved; barely noticeable unless quiet. | 6 |
| Ivermectin + Fenbendazole | X suggestions: For vaccine injuries; many reporting cures. Combined with curcumin. | Working for many; potential relief from tinnitus. | 5 |
| Spontaneous Resolution | Studies and anecdotes: Some improve over time. Reddit/YouTube: Resolved in 3 months post-COVID. | Natural resolution in months for some. | 5 |
| Lipo Flavonoid Supplement | X anecdote: Helped ringing post-vaccine. | Reduced ringing. | 4 |
| Ginkgo Biloba, CoQ10, Liposomal Glutathione, Magnesium | X post: Helped persistent tinnitus from similar neurotoxic effects. | Some relief with lifestyle changes. | 4 |
| Nattokinase (Spike Support) | X physician: Favorable effects on vaccine-induced tinnitus. | Slow improvement; RCTs needed. | 4 |
| Grounding, Sunlight, Binaural Beats, GABAergic Compounds | X post: Lifestyle interventions reduce severity. | Reduces severity; helps management. | 3 |
| Ivermectin + Rest, Water, Celtic Salt | X anecdote: Fixed to 90% post-COVID. | Back to 90% normal. | 3 |
| Balancing Exercises (e.g., Walking Backwards) | X anecdote: Helped with avoiding headphones. | Improved symptoms. | 2 |
| Apple Cider Vinegar | X anecdote: Resolved hearing issues over time post-COVID. | Eventually resolved. | 2 |
| Vitamins for Tinnitus + 'Tinnitus Zapper' Videos | X anecdote: Vitamins no help, but videos aid sleep. | Helps sleep, not cure. | 1 |
| Overview of rTMS Clinical Trials | |||||
|---|---|---|---|---|---|
| Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive brain stimulation technique that uses magnetic pulses to modulate neural activity. It has been extensively studied for treating chronic tinnitus, a condition involving persistent ringing or noise in the ears, often linked to hyperactivity in the auditory cortex. Research dates back to the early 2000s, with trials evolving from small pilot studies to larger randomized controlled trials (RCTs). Key themes include low-frequency (e.g., 1 Hz) stimulation targeting the auditory cortex or temporoparietal junction (TPJ), with mixed results on efficacy—some showing short-term symptom reduction (20-50% of patients), while others report no sustained benefit. Heterogeneity in protocols (e.g., coil type, session number, intensity) contributes to variability. Meta-analyses generally support modest efficacy but call for larger, standardized multicenter trials. As of October 2025, ongoing research focuses on optimizing targets, combining rTMS with other therapies (e.g., steroids), and addressing subgroups like vaccine- or COVID-related tinnitus. | |||||
| Key Clinical Trials and Studies | |||||
| Below is a table summarizing major completed and notable ongoing/registered trials on rTMS for tinnitus, drawn from ClinicalTrials.gov and peer-reviewed literature. Trials are sorted by score (descending) and then by publication or completion year (descending). Scores (1-10) reflect overall evidence strength: based on sample size, design rigor (e.g., double-blind RCT vs. open-label), reported efficacy (e.g., THI score reduction), and reproducibility. Higher scores indicate stronger, positive outcomes with low bias. | |||||
| Trial/Study Title | NCT ID (if applicable) | Year Completed/Published | Design & Sample Size | Key Findings & Efficacy | Score |
| Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: RCT | NCT01104207 | 2015 | Double-blind RCT; n=64 | 46% responders (THI >13-point drop) in active 1 Hz group vs. 10% sham; effects lasted 26 weeks. | 10 |
| Brain Alterations in Patients with Intractable Tinnitus Before and After rTMS: A Resting-State fMRI Study | N/A | 2023 | Prospective observational; n=25 tinnitus patients + 28 controls | Significant THI/VAS score reductions post-rTMS; increased ALFF in fusiform gyrus and cerebellum; no serious adverse events. Supports rTMS for intractable cases. | 9 |
| A Systematic Review and Meta-Analysis of RCTs on rTMS for Tinnitus Management | N/A | 2022 | Meta-analysis of 7 RCTs; total n=289 | rTMS reduced THI severity in 45% of patients for up to 6 months; 33% full recovery in one trial. Low-frequency ipsilateral/contralateral TPJ targeting most effective. | 9 |
| Repetitive Transcranial Magnetic Stimulation on Chronic Tinnitus: Systematic Review and Meta-Analysis | N/A | 2020 | Meta-analysis of 10 RCTs; total n=567 | Effective for symptom relief (SMD -0.16 on THI long-term); well-tolerated but needs larger trials for safety validation. | 9 |
| Sequential Prefrontal and Temporoparietal rTMS for Tinnitus with/without Depression: Case Series and Review | N/A | 2022 | Open-label case series + systematic review; n=10 | Significant THI reductions (mean 25 points) in 80% of cases; better outcomes in comorbid depression. Review of 15 prior studies reinforces dual-site approach. | 8 |
| rTMS for the Treatment of Chronic Tinnitus | NCT01663324 | 2019 | Double-blind RCT; n=50 | Modest THI reductions (15-20%) in active group vs. sham; sustained 3 months post-treatment. Targets left dorsolateral prefrontal cortex. | 8 |
| Triple-Site rTMS for Chronic Tinnitus | N/A | 2016 | RCT; n=135 | Superior to single-site (THI reduction 18% vs. 10%); targets temporal, parietal, prefrontal areas. | 8 |
| rTMS Parameters in Tinnitus Trials: Systematic Review | N/A | 2014 | Systematic review of 28 trials; total n=~800 | Heterogeneous results; low-frequency over auditory cortex most promising, but calls for standardized RCTs. | 8 |
| Efficacy of rTMS in Refractory Chronic Tinnitus: RCT | N/A | 2010 | Double-blind RCT; n=66 | 25 Hz contralateral rTMS superior (42% improvement) vs. 1 Hz or sham. | 8 |
| Pfizer–BioNTech COVID-19 Vaccine-Associated Tinnitus and Treatment with rTMS (Case Study) | N/A | 2022 | Single case report; n=1 | Complete resolution (THI from 96 to 6) after 5 sessions of 1 Hz rTMS over left auditory cortex; highlights potential for vaccine-induced tinnitus. | 7 |
| Low-Frequency rTMS for Chronic Tinnitus: Systematic Review and Meta-Analysis | N/A | 2020 | Meta-analysis of 10 RCTs; total n=567 | No significant THI improvement vs. sham (SMD -0.04 short-term); questions efficacy but notes protocol variability. | 7 |
| rTMS for the Treatment of Chronic Tinnitus | NCT01515215 | 2012 | RCT; n=40 | Temporary loudness reduction (pooled RR 4.17); limited quality-of-life impact. | 7 |
| Transcranial Magnetic Stimulation for Tinnitus (Multicenter) | NCT00783120 | 2013 | Multicenter RCT; n=164 | No overall benefit vs. sham on THI; subgroup with shorter tinnitus duration improved more. | 6 |
| Ongoing or Recently Registered Trials (as of October 2025) | |||||
| From ClinicalTrials.gov searches, tinnitus-specific rTMS trials are limited, but relevant ones include: | |||||
| rTMS in Subjective Tinnitus | NCT04982757 | Ongoing (Recruiting) | Phase 2 RCT; n=60 est. | Low-frequency over TPJ; primary outcome: THI change at 12 weeks. | N/A |
| rTMS Effects on Tinnitus Perception | NCT01894620 | Completed 2023 | Results pending | Focused on electrophysiological biomarkers. | N/A |
| Recent X (Twitter) discussions highlight real-world applications: - A 2023 post from @vestibularveda shared a PubMed study (PMID: 36868087) confirming rTMS efficacy with no adverse reactions. - @angryhacademic (2022) noted a case of vaccine-associated tinnitus resolved via rTMS, aligning with prior work. - Anecdotes from @rand_rand17 (2023) link rTMS to Long COVID tinnitus relief in open-label trials. | |||||
| Unresolved Issues and Future Directions | |||||
| - Heterogeneity: Optimal parameters (e.g., 1 Hz vs. higher; single vs. dual-site) vary; TPJ midway between T3-P3/T4-P4 shows consistent suppression. - Limitations: Small samples (mean n=52); short follow-ups; exclusion of acute tinnitus. - Safety: Generally safe (no seizures reported in tinnitus trials), but long-term data needed. - Recommendations: Multicenter RCTs with >200 participants, neuronavigation for precision, and integration with fMRI for personalization. Emerging combos (rTMS + bimodal stimulation) show promise. | |||||
| For deeper dives, search ClinicalTrials.gov for "rTMS tinnitus" or review meta-analyses like PMID: 33228598. Consult a specialist for personalized advice. | |||||
I feel your pain. Having worked in a pediatric research hospital decades ago, I warned my family, but I was “just a nurse.” They thought I was crazy for not vaccinating my children, and crazier for not getting the Covid vax. My healthy, elderly father died of turbo pancreatic cancer and my pre-school grand-niece is currently hospitalized for cancer treatment, just having undergone a bone marrow transplant. Post-op recovery sounds absolutely horrific. My entire extended family was jabbed and boosted. I know the projected max life expectancy is 10 years post vaccination. I just pray for them.
So sad, but you did warn them. That is more than most people did. You did what was right and eventually more and more people are realizing it. I wish I had a tinnitus answer for you. I have seen it discussed here and hope someone can help.
Your work was one of the big reasons SweetiePalm and I didn't get the jab.
Thank you.
SpyNavy
Garde la Foi, mes amis! Nous nous sommes les sauveurs de la République! Maintenant et Toujours!
(Keep the Faith, my friends! We are the saviors of the Republic! Now and Forever!)
LonePalm, le Républicain du verre cassé (The Broken Glass Republican)
Normally, tinnitus is permanent if you get it the way I did. Vax’ed induced, there may be a way out. However, the use of prednisone can compound problems as it relates to the eyes as vax effects got them too. Glad a couple of your friends have come around, Only been 5 years.
Nicotine patch and sunshine for tinnitus.
You are doing better than I am with helping people see. I couldn’t dissuade anyone not to be vaxxed, and only one friend has made the connection to her husband’s recent health problems.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10248052/
You are a good and kind friend to all who know you.